Published November 2007 | Version v1
Book

Comparison of 131I-TYR3-octreotate and 131I-DOTA-TYR3-octreotate: The effect of DOTA on pharmacokinetics and stability

  • 1. Institute of Energetic and Nuclear Research, IPEN-CNEN, Sao Paulo (Brazil)

Description

The authors compared the biodistribution, and in vivo and in vitro stabilities of 131I-Tyr3-octreotate and 131I-DOTA-Tyr3-octreotate. The peptides were radioiodinated by the chloramine T method and high radiochemical yields were obtained (greater than 97%). Both labelled compounds showed high stability when incubated in human plasma at 37 deg C. The 131I-Tyr3-octreotate showed significant hepatic uptake and biliary excretion. The biodistribution of 131I-DOTA-Tyr3-octreotate, however, can be compared with the distribution of radiometal labelled octreotide analogues. (author)

Part of:
Trends in Radiopharmaceuticals (ISTR-2005). Proceedings of an International Symposium. Vol. 2

Additional details

Publishing Information

Publisher
IAEA
Imprint Place
Vienna (Austria)
ISBN
92-0-101707-3
Imprint Title
Trends in radiopharmaceuticals (ISTR-2005). Proceedings of an international symposium. Vol. 2
Imprint Pagination
476 p.
Series
Proceedings series
Journal Page Range
p. 243-251
ISSN
0074-1884

Conference

Title
International symposium on trends in radiopharmaceuticals
Acronym
ISTR-2005
Dates
14-18 Nov 2005
Place
Vienna (Austria)

Optional Information

Notes
11 refs, 2 figs, 4 tabs
Secondary number(s)
STI/PUB--1294; IAEA-CN--130